Spots Global Cancer Trial Database for gemcitabine+erlotinib+capecitabine
Every month we try and update this database with for gemcitabine+erlotinib+capecitabine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer | NCT01303029 | Metastatic Panc... | Gemcitabine+erl... Gemcitabine+erl... | 18 Years - | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | |
| Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer | NCT01303029 | Metastatic Panc... | Gemcitabine+erl... Gemcitabine+erl... | 18 Years - | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | |
| Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer | NCT01303029 | Metastatic Panc... | Gemcitabine+erl... Gemcitabine+erl... | 18 Years - | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
